Cell-based Product Formulation
Cell-Based Product Formulation is a sterile product development approach within biopharmaceutical manufacturing that specifically involves the integration, maintenance, and delivery of viable living cells as active therapeutic components, distinguished from other sterile formulations by its reliance on cellular viability, functionality, and aseptic handling throughout the formulation process.
22
Publications
893
Citations
111
Authors
63
Institutions
Publications per year
2017–2026
8
Parents
22
1–5 of 22
111
2
h-index
1
h-index
1
h-index
1
h-index
1
h-index
1–5 of 111
63

Universitat Autònoma de Barcelona
Cerdanyola del Vallès, Spain
2 h-index
6 publications
546 citations

Leiden University Medical Center
Leiden, The Netherlands
2 h-index
5 publications
135 citations
Technical University of Munich
Munich, Germany
1 h-index
1 publications
29 citations
Catalan Society of Family and Community Medicine
Barcelona, Spain
1 h-index
2 publications
426 citations

University of Edinburgh
Edinburgh, United Kingdom
1 h-index
2 publications
60 citations
Oncology Hematology Care
Cincinnati, United States
1 h-index
1 publications
87 citations
Medicines Evaluation Board
Utrecht, Netherlands
1 h-index
1 publications
29 citations
Banc de Sang i Teixits
Barcelona, Spain
1 h-index
4 publications
120 citations
1–8 of 63
2 publications · 40 citations
2
h-index
JTM · 2 publications · 66 citations
2
h-index
Repository · 2 publications · 33 citations
2
h-index
1 publications · 25 citations
1
h-index
1 publications · 28 citations
1
h-index
1–5